Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Chemicals
  4. Organic compounds
  5. Benzenoids
  6. Benzene and substituted derivatives
  7. Nitrobenzoic acids and derivatives
  8. ML 221, Tocris Bioscience™

ML 221, Tocris Bioscience™

Catalog No. p-4816798 Shop All R&D Systems Products
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
This item is not returnable. View return policy

Description

Apelin antagonist

Apelin receptor (APJ) antagonist (IC50 values are 0.70 and 1.75 μM in a cAMP assay and β-arrestin assay, respectively). Displays >37-fold selectivity over the closely related angiotensin II type 1 (AT1) receptor. Exhibits no toxicity towards human hepatocytes at concentrations >50 μM.

Chemical Identifiers

CAS 877636-42-5
Molecular Formula C17H11N3O6S
Molecular Weight (g/mol) 385.35
InChI Key UASIRTUMPRQVFY-UHFFFAOYSA-N
Synonym 4-oxo-6-pyrimidin-2-ylsulfanylmethyl pyran-3-yl 4-nitrobenzoate, 4-oxo-6-pyrimidin-2-ylthio methyl-4h-pyran-3-yl 4-nitrobenzoate, d05nxx, 4-oxo-6-pyrimidin-2-ylsulfanyl methyl pyran-3-yl 4-nitrobenzoate, 5-4-nitrobenzoyl oxy-2-2-pyrimidinylthio methyl-4h-pyran-4-one
PubChem CID 7217941
IUPAC Name [4-oxo-6-(pyrimidin-2-ylsulfanylmethyl)pyran-3-yl] 4-nitrobenzoate
SMILES C1=CN=C(N=C1)SCC2=CC(=O)C(=CO2)OC(=O)C3=CC=C(C=C3)[N+](=O)[O-]

Specifications

Quantity 10 mg
Formula Weight 385.35
Percent Purity >99%
Chemical Name or Material ML 221

Safety and Handling

Recommended Storage Store at +4°C
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.